Alberto Garcia-Basteiro

Happy festive season to everyone! Thank you to all our partners, funders and collaborators for an excellent 2025!

💛💚💛💚

@mtbi.bsky.social
@isglobal.bsky.social
@hospitalclinic.bsky.social
@medicinacs-ub.bsky.social

👏 ¡El investigador de #ISGlobal Alberto García-Basteiro (@agbasteiro.bsky.social) se ha incorporado como nuevo miembro de la Academia Joven de España! 

🌍 Un reconocimiento que pone en valor su trayectoria científica y su compromiso con la generación de conocimiento para mejorar la #SaludGlobal.

Fantastic @theunion.org meeting in #Copenhagen. It is always great to catch up with so many friends and colleagues from all over the world.
#the #fight #against #tuberculosis
@mtbi.bsky.social
@isglobal.bsky.social

During World Science Day for Peace and Development, Dr. Dinis Nguenha from CISM shared that using the #Truenat portable molecular diagnostic system enabled 82% of TB patients to start treatment on the same day of diagnosis, improving care and reducing delays!

🗨️ Our PhD student, Salome Valencia, presented today at the XXIX Jornadas Internacionales sobre Tuberculosis 2025, hosted by #CoMB, #uiTB & #fuiTB. She explored how armed conflict and social inequality shape #TB in Colombia. Grateful to all for fostering these vital discussions!

👏 Dr. Belén Saavedra Cervera (ISGlobal & CISM) wowed audiences at the XXIX Jornadas sobre Tuberculosis 2025, presenting key findings on TB transmission in Manhiça through molecular epidemiology.

Thanks to #CoMB, #uiTB & #fuiTB!

🚨 Exciting global health opportunity!
@isglobal.org is hiring a Medical Research Fellow (Tuberculosis) in Manhiça, Mozambique.

Lead impactful TB research with a top team.
🩺 MD + 4yrs clinical exp
🗓️ 2-yr contract
🔗 Apply: jobs.isglobal.org/jobs/6376227

#GlobalHealth #TB #ResearchJobs #PublicHealth

Gaps in TB-related knowledge and practices: An assessment of health care seeking behavior among adults with HIV and caregivers of paediatric patients with presumptive TB symptoms in Manhiça district, ... Although tuberculosis is a preventable and treatable disease, its management has been challenging for tuberculosis control and prevention programs in low- and middle- income countries such as Mozambiq...

🔍 New MTBI-led study shows gaps in #TB awareness in #Mozambique particularly among adults w/ #HIV and caregivers of children.

🛑 Low TB knowledge
⚠️ Stigma
🚫 Gender barriers

Call for community-driven interventions.

📖 journals.plos.org/globalpublic...

#GlobalHealth #PublicHealth #HealthEquity

Figure 1. Estimated number of trial endpoints in the control group of a prevention-of-disease vaccine trial in a high disease-burden setting showing number of endpoints on the y-axis and time in months on the x-axis. For bacteriologically confirmed symptomatic tuberculosis disease endpoints only, we estimate 69 endpoints, and for combined bacteriologically confirmed asymptomatic and symptomatic tuberculosis disease endpoints, we estimate 151 endpoints. Scenario assumes symptomatic disease incidence before trial screening of 300/100 000 per year and following 10 000 individuals over 3 years. Prevalent symptomatic and asymptomatic tuberculosis disease are screened out in month 0 and are not trial endpoints. Active screening occurs every 6 months for both scenarios and participants self-presenting with symptoms suggestive of tuberculosis disease would also be investigated.

In our latest personal view in @lancetrespirmed.bsky.social, we argue for the inclusion asymptomatic #tuberculosis in vaccine trial endpoints to potentially reduce the size, length, and cost of trials.

doi.org/10.1016/S221...

@lshtm-tbmod.bsky.social @tb-lshtm.bsky.social

La Fundación Banco Sabadell premia dos investigadores por sus trabajos sobre la tuberculosis y sobre el diseño computacional de enzimas - Fundación Banco Sabadell

💥Today we share great news! @agbasteiro.bsky.social has been honored with the XX Banc Sabadell Foundation Award for Biomedical Research! 👏🏾

🔗 fundacionbancosabadell.com/la-fundacion...

#PremiosBiomédicaCiencias #LaCulturadelTalento #Investigación

Ensayos de vacunas en prisiones - ISGLOBAL Sobre el derecho de las personas privadas de libertad a participar en investigaciones biomédicas, siempre que se respete su autonomía y sus derechos

Deben participar las personas encarceladas en ensayos de vacunas contra la #TB?

"Hay que garantizar ensayos seguros y éticos para una vacuna que podría proteger su salud y la de sus familias", dice @agbasteiro.bsky.social.

#EndTB

Spain increases 11.5%its contribution to @Globalfund Fund, to fight #AIDS #TB and #malaria.

Bravo!

www.exteriores.gob.es/es/Comunicac...

Great collaborative piece with top experts in the field of #TB in prisons @jasonandrews.bsky.social @juliocroda.bsky.social and other renown epidemiologists!

We just published a piece about the participation of people deprived of liberty in #tuberculosis vaccine trials. Should they be protected from research, or through research?

www.thelancet.com/journals/lan...

@thelancetinfdis.bsky.social @isglobal.org @mtbi.bsky.social

#MTBI was proud to join the 12th #EDCTP Forum last week in Kigali, Rwanda. The event brought together global leaders to advance clinical research and partnerships in sub-Saharan Africa. A great opportunity to connect, share insights, and support better health through global collaboration.

I am grateful for the opportunity to present at the #EDCTPforum in Kigali. We had a great session on #Tuberculosis prediction and early TB trajectories, with Shima Abdulgader and Edson Marambire. Chaired by @kkranzer.bsky.social & @willyssengooba.bsky.social

Great opening ceremony of the #EDCTPforum in Kigali, Rwanda 🇷🇼 Excited to be here and meet many colleagues and friends.

Presenting this upcoming Tuesday on the science of #tuberculosis prediction

@isglobal.org @mtbi.bsky.social @ub.edu

#MTBI members Dr. Lucía Carratalá & @joannaehrlich.bsky.social ‪joined other colleagues to present updates on the final key study results, main indicators & data management.

👏A great opportunity to showcase the hard work behind Impactful research on the advances in TB diagnostics.

#endTB #Stool4TB

The #Stool4TB Consortium Annual Meeting in Eswatini kicked off with opening remarks from Dr. @agbasteiro.bsky.social, PI of the #MTBI initiative, and Ms. Rejoice Nkambule, Deputy Director of Public Health at Eswatini’s Ministry of Health.

(Stool4TB)

This achievement highlights the power of collaboration, innovation, and commitment to advancing global health.

#Stool4TB focuses on validating a qPCR stool-based test designed to improve TB diagnosis in children and people living with HIV.

🔗 Learn more: www.stool4tb.org

✨The final annual meeting of the #Stool4TB Consortium in Mbabane, Eswatini, was a great success — marking the conclusion of five years of collaborative research to improve tuberculosis diagnosis.
Partners from across Eswatini, Uganda, and Mozambique came together to celebrate a major milestone!

Today @prados-rosales.bsky.social came to visit us. His presentation on extracellular vesicles for #TB diagnosis was extremely interesting and engaging. Come back soon Rafa!!

@mtbi.bsky.social @isglobal.org

🟡 We're pleased to be participating in the TBnet Academy in Tirana this week!

📸 Today, Dr. @agbasteiro.bsky.social delivered a talk on Asymptomatic Tuberculosis, sharing insights on one of the most challenging aspects of TB control.

#TBnetAcademy #endTB #MTBI

Alberto García-Basteiro (@agbasteiro.bsky.social) has been recognised as a “Fellow” by the European Respiratory Society — one of the highest honours in the field of respiratory medicine. 👏 Congratulations, Alberto!

🟠 www.isglobal.org/en/-/alberto...

I am happy to share this piece about "Transforming partnerships through transboundary research" published in BMJ Global Health.

It addresses the structural asymmetries that continue to affect collaborations in global health

@isglobal.bsky.social @mtbi.bsky.social

gh.bmj.com/content/bmjg...

Performance of stool-based molecular tests and processing methods for paediatric tuberculosis diagnosis: a systematic review and meta-analysis This systematic review and meta-analysis supports the use of Xpert Ultra in stool samples as a diagnostic tool for paediatric tuberculosis diagnosis. Stool-based Xpert Ultra can contribute to increase...

Sí!! Muchos papers en pediatría
www.thelancet.com/journals/lan...

Performance of stool Xpert MTB/RIF Ultra for detection of Mycobacterium tuberculosis among adults living with HIV: a multicentre, prospective diagnostic study These results suggest stool Ultra could be used as an additional test for tuberculosis diagnosis among people with HIV, particularly among those with CD4 counts less than 200 cells per μL.

Latest #Stool4TB research! Performance of stool Xpert Ultra for #Tuberculosis diagnosis among adults with #HIV

The study suggests it could be used as a complementary test in PLHIV, especially in those with low CD4

@hospitalclinic.bsky.social @isglobal.org @ub.edu

www.thelancet.com/journals/lan...

Changes in incarceration and tuberculosis notifications from prisons during the COVID-19 pandemic in Europe and the Americas: a time-series analysis of national surveillance data Tuberculosis notifications in prisons from 47 countries in Europe and the Americas were lower than expected (at times >50% lower) during COVID-19 pandemic years, despite consistent incarceration level...

Changes in incarceration and #tuberculosis notifications from prisons during the #COVID-19 pandemic in Europe & the Americas: a time-series analysis of national surveillance data

Lower than expected #TB notifications! due to missing diagnoses? Lower transmission?

www.thelancet.com/journals/lan...

👏🏾 El debate de ayer de #CaixaResearch sobre #Tuberculosis fue imprescindible. La enfermedad infecciosa más mortal del mundo fue analizada en profundidad por @agbasteiro.bsky.social, @pjcardona14.bsky.social e Iñaki Comas.

➡️ Si te lo perdiste, aún puedes verlo: www.youtube.com/watch?v=USQv...

❗Hoy participamos en un debate de Caixa Research sobre #TB.
Estará uno de nuestros PI @agbasteiro.bsky.social, junto con @pjcardona14.bsky.social e Iñaki Comas, con la moderadora Jessica Mouzo.

¡No os lo perdáis!
Apúntate: caixaresearch.org/es/debates-c...

#endTB #MTBI #CaixaResearch